Jardiance Contraindications



Boehringer Ingelheim


Metro Drug
Full Prescribing Info
Hypersensitivity to the empagliflozin or any of the excipients.
Patients with CKD stage 4 or 5 (severely impaired renal function including patients receiving dialysis; eGFR < 30 mL/min/1.73m2 or CrCl < 30 mL/min) or eGFR persistently < 45 mL/min/1.73m2 or CrCl persistently < 45mL/min (CKD Stage 3B). The efficacy of Empagliflozin (Jardiance) is dependent on renal function (see Precautions).
In case of rare hereditary conditions that may be incompatible with an excipient of the product (please refer to Precautions), the use of the product is contraindicated.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in